Solara Active Pharma Sciences informs about disclosure

11 Jun 2024 Evaluate

Solara Active Pharma Sciences has informed that the exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on June 10, 2024 for SRJR Enterprise LLP & PACs.

The above information is a part of company’s filings submitted to BSE.

Solara Active Pharma Share Price

530.10 -7.95 (-1.48%)
04-Apr-2025 09:30 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1739.15
Dr. Reddys Lab 1136.30
Cipla 1460.05
Lupin 2054.00
Zydus Lifesciences 884.20
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...